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ABSTRACT 
1 
2 The epithelial cells lining the thick ascending limb (TAL) of the loop of Henle 3 
4 
5 perform essential transport processes  and secrete uromodulin, the most abundant 
6 
7 protein in normal urine. The lack of differentiated cell culture systems has hampered 8 
9 
10 studies of TAL functions. Here we report a method to generate differentiated primary 
11 
12 cultures of TAL cells, developed from microdissected tubules obtained in mouse 
13 
14 kidneys. The TAL tubules cultured on permeable filters formed polarized confluent 
16 
17 monolayers in ~12 days. The TAL cells remain differentiated and express functional 
18 
19 markers  such  as  uromodulin,  NKCC2  and  ROMK  at  the  apical  membrane. 20 
21 
22 Electrophysiological measurements on primary TAL monolayers showed a lumen- 
23 
24 positive transepithelial potential (+9.4±0.8 mV/cm2) and  transepithelial resistance 25 
26 
27 similar to that recorded in vivo. The transepithelial potential is abolished by apical 
28 
29 bumetanide  and  in  primary  cultures  obtained  from  ROMK  knockout  mice.  The 
30 
31 processing, maturation and apical secretion of uromodulin by primary TAL cells is 
33 
34 identical to that observed in vivo. The primary TAL cells respond appropriately to 
35 
36 hypoxia, hypertonicity and stimulation by desmopressin, and they can be transfected. 37 
38 
39 The establishment of this primary culture system will allow the investigation of TAL 
40 
41 cells obtained from genetically modified mouse models, providing a critical tool for 42 
43 
44 understanding the role of that segment in health and disease. 
45 
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of calcium crystal aggregation [27]; and regulation of the activity of NKCC2 and/or 
ROMK  [31,37].  Mutations  in  the  UMOD  gene  that  codes  for  uromodulin  are 
responsible for defective processing of uromodulin in the TAL, leading to tubular 
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INTRODUCTION 
1 
2 The  mammalian  kidney  is  characterized  by  a  complex  tubular  segmentation, 3 
4 
5 reflecting specialized functions and regulatory pathways. The thick ascending limb 
6 
7 (TAL) of the loop of Henle plays essential roles in the reabsorption of sodium, the 8 
9 
10 handling of divalent cations, and the urinary concentrating ability. The reabsorption of 
11 
12 sodium by  the  TAL  cells  involves the  apical,  bumetanide-sensitive Na+,K+,2Cl-- 
13 
14 cotransporter  NKCC2,  organized  in  parallel  with  the  renal  outer  medullary  K+ 
16 
17 (ROMK) channel [16]. The K+ recycling activity of ROMK contributes to the lumen- 
18 
19 positive  transepithelial  potential,  which  favours  the  paracellular  reabsorption  of 20 
21 
22 sodium and divalent cations in that segment [13,23]. The activity of NKCC2 in the 
23 
24 TAL is regulated by the antidiuretic hormone arginine vasopressin (AVP), via type 2 25 
26 
27 receptors (V2R) [3]. 
28 
29 In addition to high transport activity, the epithelial cells lining the medullary 
30 
31 TAL are characterized by their ability to cope with hypertonicity and relative hypoxia. 
33 
34 The osmoprotective response is ensured by multiple pathways that converge to the 
35 
36 transcription factor tonicity-responsive enhancer binding protein (TonEBP) [7]. The 37 
38 
39 high energy demands of medullary TAL cells are challenged by poor medullary blood 
40 
41 flow [18]. This difficulty is balanced by the hypoxia-inducible factor (HIF) pathway, 42 
43 
44 which plays a major role to protect the cells against oxygen deprivation [39]. 
45 
46 The  TAL  cells  are  the  exclusive  production  site  of  uromodulin  (Tamm- 47 
48 
Horsfall protein), the most abundant protein secreted in the normal urine [35]. The 
50 
51 roles of uromodulin include protection against urinary tract infections [4]; prevention 
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dysfunction and progressive renal failure [11,35]. Recently, genome wide association 
1 
2 studies (GWAS) revealed that variants in UMOD are associated with the risk of 3 
4 
5 developing chronic kidney disease in the general population [25]. There is thus a 
6 
7 strong  rationale to obtain a TAL cellular system able to decipher the role(s) of 8 
9 
10 uromodulin in both monogenic diseases and complex disorders. 
11 
12 As compared with the proximal tubule, fewer cell lines derived from the TAL 
13 
14 have been proposed. Techniques based on magnetic separation by antibodies [1,34], 
16 
17 density  gradient  centrifugation  [9,14,20],  microdissection  [8,42,44],  and  sieving 
18 
19 [19,24] have been used to isolate primary TAL cells. Immortalized TAL cells have 20 
21 
22 also been obtained from transgenic SV40 mice [6,10]. These culture systems are, to a 
23 
24 variable extent, limited by insufficient purity and loss of terminal differentiation (lack 25 
26 
27 of TAL markers). Furthermore, they have been insufficiently characterized in terms of 
28 
29 transport  and  response  to  environment  (hypoxia,  osmotic  stress)  and  hormonal 
30 
31 stimulation. Since primary cultures were usually obtained from rat and rabbit kidney, 
33 
34 they could not take advantage of genetically modified mouse models. Finally, to the 
35 
36 best of our knowledge, none of the TAL cell systems has been shown to conserve the 37 
38 
39 complex processing of uromodulin as observed in vivo. 
40 
41 We report here the establishment of a primary culture system based on pure 42 
43 
44 TAL segments microdissected from mouse kidney and grown on permeable filters. 
45 
46 These polarized monolayers display morphological features and critical functions of 47 
48 
TAL  cells  in  vivo,  including  electrophysiological  properties  and  processing  of 
50 
51 uromodulin. 
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morphology characteristics (Fig.   1A), using a glass pipet connected to a 
micromanipulator  (Narishige  International,  London,  UK).  Pooled  TAL  segments 
(typically, ~50 collected) were placed onto 0.33 cm² collagen-coated PTFE filter 
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MATERIALS AND METHODS 
1 
2 Primary cell culture of mouse TAL cells 3 
4 
5 Primary cell cultures of mouse TAL (mTAL) cells were prepared using a modified 
6 
7 version of previously described protocols [24,41]. Three to 6 week-old wild-type mice 8 
9 
10 (C57/BL6 (Charles River, Suzbach, Germany), uromodulin knockout [30], ROMK 
11 
12 knockout [28], and parvalbumin-EGFP [29] lines) were sacrificed with sevoflurane 
13 
14 (Abbott Laboratories, Abbott Park, Illinois, USA). Kidneys were removed and placed 
16 
17 into ice-cold HBSS dissection solution (Lonza, Verviers, Belgium), supplemented 
18 
19 with  15  mM  hepes  (Lonza),  10  mM  D-glucose  (VWR  International,  Lucerne, 20 
21 
22 Switzerland), 5 mM glycine (VWR International) and 1 mM L-alanine (Applichem 
23 
24 GmbH, Darmstadt, Germany), pH 7.4, 325 mOsm/kg H2O. Each kidney was cut 25 
26 
27 along the midsagittal plane into two halves, and further into transverse sections. After 
28 
29 removing the cortex and inner medulla, the outer medulla was cut into 1 mm-square 
30 
31 pieces, followed by a 30-min treatment in dissection solution supplemented with 245 
33 
34 units/ml type-2 collagenase (Worthington Biochemical Corp, Lakewood, USA) and 
35 
36 96  µg/  ml  soybean trypsin  inhibitor (Sigma, St.  Louis, USA).  The  collagenase- 37 
38 
39 digested segments were sieved through a 250 µm filter (BVBA Prosep, Zaventem, 
40 
41 Belgium) and collected on a 80 µm filter (BVBA) to obtain tubules longer than 100 42 
43 
44 µm. The sieved tubular segments were collected in 37oC albumin solution (dissection 
45 
46 solution  supplemented  with  1%  (w/v)  BSA  (VWR  International)  and  96  µg/ml 47 
48 
49 soybean trypsin inhibitor (Sigma)). The TAL tubules were viewed under a light 
50 
51 microscope  (Leica  DM  IL,  Bensheim,  Germany)  and  selected  on  the  basis  of 
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SYBR  Green  Supermix  (Bio-Rad)  and  an  iCycler  IQ  System  (Bio-Rad).  The 
following PCR conditions were used: 94°C for 3 min, followed by 40 cycles of firstly 
30 sec at 95°C, secondly 30 sec at 61°C and finally 1 min at 72°C. All amplicons 
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membranes (Transwell-COL, pore size 0.4 µm, Corning Costar, USA) in culture 
1 
2 medium DMEM:F12 (Gibco-BRL, Breda, The Netherlands) supplemented with 15 3 
4 
5 mM HEPES (Gibco-BRL), 0.55 mM Na-pyruvate (Gibco-BRL), 0.01% (v/v)  non- 
6 
7 essential  amino  acids  (Gibco-BRL),  2%  (v/v)  FBS  (Lonza)  and  one  batch  of 8 
9 
SingleQuots® (Lonza), pH 7.4 and incubated in a humidified chamber at 37°C – 5% 
11 
12 CO2. The medium was changed every 48 h. A confluent monolayer of TAL cells 13 
14 expanded from the tubular fragments after ∼12 days. 
16 
17 When  the  cultures  were  close  to  forming  confluent  monolayers,  the  cells  were 
18 
19 cultured  under  low  serum  conditions  (0.1%  for  4-6  days)  to  allow  maximal 
21 
22 differentiation. Typically primary TAL cells were harvested, and apical medium was 
23 
24 collected, after  4  days  at  low  serum conditions. Following 0.04%  (w/v)  trypsin 25 
26 
27 (Gibco-BRL) treatment, the primary TAL cultures could be passaged to either new 
28 
29 0.33 cm² collagen-coated PTFE filter membranes (1 to 6 dilution) or 24-well plastic 30 
31 
32 culturing plates (Nunc™ Cell Culture 24-well MicroWell; 1 to 4 dilution). 
33 
34 
35 
36 SYBR Green real-time quantitative PCR 
38 
39 Total RNA was extracted from isolated segments and primary cultures using the 
40 
41 RNAqueousR    kit   (Applied  Biosystems  Inc,   Foster   city,  USA),   according  to 42 
43 
44 manufacturers protocol. The obtained RNA was subjected to DNase treatment and 
45 
46 reverse  transcriptased  by  using  the  iScriptTM    cDNA  Synthesis  Kit  (Bio-Rad, 47 
48 
49 München, Germany). RT-qPCR analyses were performed in duplo using 100 nM of 
50 
51 both sense and anti-sense primers (Table 1) in a final volume of 20 µl using iQTM 
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(Sigma) and incubated for 1h using 3% (v/v) blocking serum. The primary antibody 
was diluted in PBS (Gibco-BRL) containing 2% (w/v) BSA (VWR International) and 
incubated for 1 h at room temperature. After four PBS washing steps, monolayers 
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32 
showed expected sizes and the dissociation curves showed one melting peak, ensuring 
1 
2 the  absence  of  a  non-specific  by-product  or  primer  dimers.  Glyceraldehyde  3- 3 
4 
5 phosphate dehydrogenase (Gapdh) was used routinely as a reference gene, since 
6 
7 preliminary experiments showed no significant differences with other reporter genes 8 
9 
10 (Cyclophilin, Hprt1, Actb, 36b4). The relative changes in target gene/GAPDH mRNA 
11 
12 ratio were determined by the formula: 2 ΔΔct. 
13 
14 
15 
16 
17 Antibodies 
18 
19 The  following  antibodies  were  used  for  immunostaining and/or  immunoblotting: 20 
21 
22 sheep anti-uromodulin (Meridian #K90071C) and rabbit anti-uromodulin (gift of Prof. 
23 
24 F.  Serafini-Cessi); rabbit  anti-NKCC2 (Millipore #AB3562P);  rabbit  anti-ROMK 25 
26 
27 (directed against a GST-fusion protein containing amino acids 342-391 of rat ROMK, 
28 
29 and affinity-purified on maltose-binding protein comprising the same epitope.  The 
30 
31 specificity of the anti-ROMK antibodies has been validated on ROMK knockout 
33 
34 mouse tissue (immunostaining) and inducible cell lysates (immunoblotting) (Johannes 
35 
36 Loffing and Olivier Staub, personal communication); rabbit anti-AQP1 (Millipore 37 
38 
39 #AB2219); rabbit anti-AQP2 (Sigma #A7310); and monoclonal mouse anti-β-actin 
40 
41 (Sigma #A5441). 42 
43 
44 
45 
46 Immunostaining 47 
48 
49 Confluent monolayers of primary cultured TAL were fixed for 10 min by 4% (w/v) 
50 
51 paraformaldehyde (Sigma), permeabilized for  5  min in  0.2%  (v/v) Triton X-100 
52 
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HRP, P0163; goat anti-rabbit HRP, P0488; both from Dako, Glostrup, Denmark), 
washed  and visualized by  Immun-Star™  enhanced chemiluminescence (Bio-Rad). 
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were  incubated  with  Alexa  Fluor®   secondary  antibodies  (Invitrogen,  Breda,  the 
1 
2 Netherlands: goat anti-rabbit alexa 633 (A-21071); donkey anti-sheep alexa 633 (A- 3 
4 
5 11015)) for 30 min at room temperature. After PBS washing, filters were cut from the 
6 
7 holder  and  mounted  in  Prolong  Gold  Anti-fade  reagent  (Invitrogen).  The  same 8 
9 
10 procedure  was  used  to  stain  paraffin-embedded  sections  from  mouse  kidneys. 
11 
12 Sections  were  viewed  using  a  LSM510Meta  Confocal  microscope  (Carl  Zeiss, 
13 
14 Oberkochen, Germany), with an x63/1.4 Plan-Apochromat oil-immersion objective. 
16 
17 
18 
19 Immunoblotting 20 
21 
22 Immunoblotting was performed as described previously [17]. In short, mouse kidneys, 
23 
24 isolated segments and confluent primary mTAL monolayers were solubilised in lysis 25 
26 
27 buffer (1mM EDTA (Merck), 20 mM imidazole (AppliChem GmbH, Darmstadt, 
28 
29 Germany), 250 mM sucrose (VWR)) containing Complete Mini protease inhibitors 
30 
31 (Roche  Diagnostics,  Brussels,  Belgium),  followed  by  a  brief  sonication  and 
33 
34 centrifugation at 16,000 g for 1 min at 4°C. Protein concentrations were determined 
35 
36 using the bicinchoninic acid (BCA) protein assay (Pierce, Aalst, Belgium). Samples 37 
38 
39 were thawed on ice, normalized for protein levels, diluted in Laemmli sample buffer 
40 
41 (Bio-Rad)  and  separated  by  sodium  dodecyl  sulphate  (SDS)  polyacrylamide gel 42 
43 
44 electrophoresis (PAGE) and blotted onto nitrocellulose. Membranes where blocked 
45 
46 for 30 min in 5% w/v non-fat dry milk solution at room temperature, followed by 47 
48 
overnight incubation at 4°C with primary antibodies. Thereafter blots where washed 
50 
51 and incubated with peroxidase-conjugated secondary antibodies (rabbit anti-sheep 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
and Endohm 6 electrodes (WPI). The effect of NKCC2 inhibition was tested after 
incubation with 100 µM bumetanide (Sigma) for 5 min. 
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37 
Immunoblots  were  quantified  by  densitometry  using  ImageJ  (Image  Processing 
1 
2 Program, NIH, USA) software. 3 
4 
5 
6 
7 Transmission electron microscopy 8 
9 
10 Primary  TAL  cells  on  permeable  filter  supports  were  fixed  with  0.8%  (m/v) 
11 
12 formaldehyde (EMS, München, Germany) and 2.5% (m/v) glutaraldehyde (Fluka, 
13 
14 Buchs SG, Switzerland) buffered in 0.1 M sodium cacodylate (Merck) for 30 min, 
16 
17 followed by additional overnight incubation in 0.1 M sodium cacodylate buffer. The 
18 
19 cells were postfixed for 30 min in 1% (m/v) osmium tetraoxide (EMS) buffered in 0.1 20 
21 
22 M sodium cacodylate, dehydrated in a graded series of ethanol and propylene oxide 
23 
24 (Fluka) and  embedded in  epoxy  resin  (Fluka).  Sections were  prepared using  an 25 
26 
27 ultracryomicrotome (UltracutUCT, Leica, Bensheim, Germany). Semi-thin (200 µm) 
28 
29 sections  stained  with  toluidine  blue  (Fluka)  were  analysed by  light  microscopy. 30 
31 
32 Ultrathin (65 nm) sections were mounted on Athene schlitz copper grids (Plano, 
33 
34 Wetzlar, Germany), contrasted with uranyl acetate dihydrate (Fluka) and lead citrate 35 
36 (Merck) and investigated by use of a Philips CM100 (Eindhoven, The Netherlands) 
38 
39 transmission electron microscope. 
40 
41 
42 
43 
44 Electrophysiology 
45 
46 Confluent primary TAL monolayers (from wild-type and ROMK knockout mice) on 47 
48 
49 filters were subjected to simultaneous transepithelial potential difference (Vte) and 
50 
51 resistance (R) measurements using an EVOM-G potentiometer (WPI, Sarasota, USA), 
52 
53 
54 
55 
56 
57 
58 
59 
60 
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62 
63 
64 
65 
(Sigma) for 5 min at room temperature at both the apical and basolateral side of the 
filter   support.   The   dose-response   curve   was obtained  by   applying   different 
concentration  of  dDAVP  (10-7 10-12 to M)  at the  basolateral  side.  The  cAMP 
10 
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Uromodulin recovery and shedding experiments 
1 
2 Confluent monolayers of TAL cells grown on filter support were used for uromodulin 3 
4 
5 recovery  and  shedding  experiments.  After  collection  of  the  last  48-h  apical 
6 
7 supernatant, the cells were washed twice with 37 oC PBS, followed by application of 8 
9 
10 200 μl of fresh medium to the apical compartment. Samples (20 μl) of apical medium 
11 
12 were taken after 2, 4, 8, 12 and 16 h to assess uromodulin level by immunoblotting. 
13 
14 The influence of apical protease activity on the shedding of uromodulin was assessed 
16 
17 by treating primary TAL monolayers with a protease inhibitor cocktail (PIC, P8340, 
18 
19 Sigma) (1:1000 v/v in apical medium) for 16h, after which uromodulin concentration 20 
21 
22 in the apical medium was measured by immunoblotting. 
23 
24 
25 
26 
27 Hypoxic and hypertonic treatment of primary TAL cells 
28 
29 To address the hypoxic response, mouse primary TAL cells were cultivated at 37 oC 
30 
31 for 24 h at low oxygen (0.2%) in a Ruskinn Invivo2 400 incubator (Bridgend, United 
33 
34 Kingdom) and compared to cells cultured at normal oxygen (21%) concentration. To 
35 
36 study the hypertonic response, primary TAL cells were cultured at 37 oC for 6 h under 37 
38 
39 isotonic (320 mOsm) or hypertonic (480 mOsm) conditions (by addition of NaCl to 
40 
41 the medium). Following the exposure to hypoxia or hypertonic conditions, the cells 42 
43 
44 were harvested to extract mRNA and perform RT-qPCR. 
45 
46 
47 
48 
Treatment with DDAVP and cAMP assay 
50 
51 Primary TAL cultures were stimulated by 10-8 M of V2 receptor agonist DDAVP 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Protein precipitation and deglycosylation 
Proteins  present  in  the  extracellar  medium  (75µl)  or  mouse  urine  (5µl)  were 
precipitated by adding 4 volumes of acetone to the samples. The pellets were dried for 
11 
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concentration  was  determined  by  use  of  the  DetectX®   Cyclic  AMP  enzyme 
1 
2 immunoassay kit  (Arbor  Assays,  Ann  Arbor,  USA),  according to  manufacturers 3 
4 
5 recommendations. 
6 
7 
8 
9 
10 Transfection of primary TAL monolayers 
11 
12 Transfections were carried out for 24h in primary mTAL cells reaching 90% of 
13 
14 confluence. After transfer in medium without antibiotics, cells were transfected with 
16 
17 50nM   of   BLOCK-iTTM    Alexa555  Red  Fluorescent  Oligo  (fluorescence-based 
18 
19 indication of transfection efficiency) diluted in Opti-MEM containing 20 
21 
22 Lipofectamine™ RNAiMAX (Invitrogen, Breda, The Netherlands). The medium was 
23 
24 changed 6h after transfection. Control cells were transfected with a non-fluorescent 25 
26 
27 SilencerRNegative control siRNA (Invitrogen) in the same conditions. 
28 
29 The  RNA  interference  experiment  against  UMOD  was  performed  with  small 
30 
31 interference  RNA  (siRNA)  with  21  nucleotides  (SilencerR   Select  Pre-designed 
33 
34 siRNA; Ambion). To knockdown the endogenous UMOD expression, 3 different 
35 
36 double-strand siRNA (50nM) were introduced into prTAL cells using 37 
38 
39 LipofectamineTM RNAiMAX (Invitrogen). Control cells were transfected with a non- 
40 
41 fluorescent SilencerRNegative control siRNA (Invitrogen) in the same conditions. 42 
43 
Total RNA was extracted 48 h after transfection using RNAqueousR-Micro kit, prior 
45 
46 to RT-qPCR  analyses for  the expression of Umod (target) and Clcn5 (non-specific 47 
48 
gene expressed in TAL). 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
spectrum acquired in the orbitrap from m/z 300-1750 with 60.000 resolution. Target 
ions  selected  for  the  MS/MS  were  fragmented in  the  ion trap  and  dynamically 
excluded for 120s. Target value were 1,000,000 for survey scan and 100,000 for 
12 
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30 min and resuspended in PBS. Samples were deglycosylated using peptide-N-(N- 
1 
2 acetyl-β-glucosaminyl) asparagine  amidase  (PNGase  F)  (New  England  Biolabs), 3 
4 
5 according to the manufacturer recommendations. In short, each sample was incubated 
6 
7 for 15 min at 55°C in denaturing buffer, followed by 1 h incubation at 37°C in G7 8 
9 
10 buffer containing 1% NP-40 and 0.5 μl of PNGase F. 
11 
12 
13 
14 Mass spectrometry analysis 
16 
17 Deglycosylated  proteins  or  urinary  samples  were  alkylated  in  55  mM  IAA 
18 
19 (Iodoacetamide) for 20 min at room temperature, separated on 8% acrylamide SDS– 20 
21 
22 PAGE and stained with Coomassie Brilliant Blue (Sigma–Aldrich). 
23 
24 nLC-MS/MS analysis: Band of interest was excised from gel, subjected to reduction 25 
26 
27 (10 mM DTT) alkylation (55 mM IAA) and digestion with Asp-N (Roche) [38]. 
28 
29 Peptide mixtures were concentrated, desalted [36] and analyzed on a LTQ-Orbitrap 
30 
31 mass spectrometer (Thermo Fisher Scientific) equipped with a nanoelectrospray ion 
33 
34 source (Proxeon Biosystems, Odense, Denmark) and coupled on line to an Easy-nLC 
35 
36 (Proxeon).   Peptide separations occurred on a RP homemade 25 cm reverse-phase 37 
38 
39 spraying fused silica capillary column (75 μm i.d. × 25 cm), packed with 3 μm 
40 
41 ReproSil-Pur C18-AQ (Dr. Maisch GmbH, Germany). A gradient of eluents A (H2O 42 
43 
44 with 2% v/v ACN, 0.5% v/v acetic acid) and B (80%ACN with 0.5% v/v acetic acid) 
45 
46 was used to achieve separation, from 4% B (at 0 min 0.15 μL/min flow rate) to 70% B 47 
48 
(in 65 min, 0.15 μL/min flow rate). 
50 
51 MS and MS/MS spectra were acquired selecting the ten most intense ions per survey 
52 
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MS/MS scan. For accurate mass measurements, the lock-mass option was employed 
1 
2 [33] selecting the 371.1012 amu ion. 3 
4 
5 Database search: The acquired MS files were converted into peaklist (.msm files) and 
6 
7 analyzed using Mascot (Matrix Science, London, UK;  version 2.2.0.7)  searching 8 
9 
10 against the uniprot_cp_mus_2013_02 database (50287 sequences; 24229016 
11 
12 residues). Searches were performed using semi_Asp-N cleavage option; a fragment 
13 
14 ion   mass   tolerance   of   0.60   Da   and   a   parent   ion   tolerance   of   5.0   ppm. 
16 
17 Carbamidomethylation of cysteine was specified as a fixed modification; oxidation of 
18 
19 methionine, asparagine deamidation and acetylation of the N-terminus of proteins 20 
21 
22 were specified as variable modifications. 
23 
24 
25 
26 
27 Statistical analysis 
28 
29 All values are expressed as mean ± SEM. Overall statistical analyses were performed 
30 
31 by Student’s t-test. P<0.05 is considered statistically significant. 
33 
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microdissection and  isolation procedure yielded a  high enrichment of  pure TAL 
segments. 
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49 
RESULTS 
1 
2 Microdissection and isolation of pure TAL tubules 3 
4 
5 The outer medulla from 4 to 6-week old mouse kidneys was dissected and treated 
6 
7 with collagenase to obtain single tubule fragments. These segments included some 8 
9 
10 glomeruli and proximal convoluted tubules (PCT), and numerous proximal straight 
11 
12 tubules (PST), TAL and connecting tubules/collecting ducts (CNT/CD) (Figure 1). 
13 
14 The tubular segments could be distinguished by simple morphological criteria (Fig. 
16 
17 1A). Both the PCT and PST showed a large diameter (~60μm). The PCT presented 
18 
19 many convolutions, with an open lumen, while the PST are straight, darker, and have 20 
21 
22 a collapsed v-shaped lumen. The TAL tubules showed a smaller diameter (~30μm) 
23 
24 and smooth structure, and they rarely presented an open lumen. The CNT and CD 25 
26 
27 tubules had a light-coloured cobblestone appearance and branching. 
28 
29 We  collected  50-60  of  each  of  these  segments  to  investigate  the  expression  of 
30 
31 segment-specific  marker  genes  by  using  reverse  transcriptase  PCR  (RT-PCR). 
33 
34 NKCC2  and uromodulin (UMOD)  were expressed in the TAL, but not in other 
35 
36 segments. In contrast, aquaporin-1 (AQP1) and N-glutamine transporter 3 (SNAT3); 37 
38 
39 aquaporin-2 (AQP2); and podocin were not detected in the TAL tubules (Figs. 1B,C). 
40 
41 The  TAL  preparations were  also  negative for  the  Na+-Cl-  cotransporter NCC,  a 42 
43 
44 marker  of  the  distal  convoluted tubule (with  positive  control  obtained  from  the 
45 
46 parvalbumin-EGFP mouse; data not shown). Real-time qPCR was used to confirm the 47 
48 
enrichment  of  microdissected fragments  with  their  respective  markers,  including 
50 
51 NKCC2 and UMOD for the TAL (Fig. 1C). Altogether, these data indicate that the 
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apparent patchy staining of uromodulin was in fact reflecting the undulant topology of 
the  primary TAL  monolayers as  shown on  the  ZY-stack image (Fig.  3A). This 
staining  pattern  was  similar  to  the  one observed  in  mouse  kidney,  where both 
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Culture of TAL tubules on collagen-coated filter supports 
1 
2 Following microdissection, ~50 tubules were placed on a filter support to obtain the 3 
4 
5 primary cultures (Figure 2). The cultures (n= ~10 per kidney) were seeded within 2 h 
6 
7 after dissection. The formation of small cell islands, usually starting at the end of the 8 
9 
10 tubules, was observed during the first 4-5 days. These islands joined after ~10 days, to 
11 
12 form confluent cultures on filters at ~12 days after seeding (Fig. 2A). 
13 
14 Morphological examination of  confluent  primary  TAL  cultures  grown  on  filters 
16 
17 revealed well-polarized monolayers of cuboidal epithelial cells (9-10 μm high) on 
18 
19 transverse sections (Fig. 2B). Ultrastructural examination by transmission electron 20 
21 
22 microscopy (Figs.  2C-F)  showed  that  the  cells are  characterized by  short  apical 
23 
24 microvilli (Figs. 2C,D), well-developed rough endoplasmic reticulum (Fig. 2D), large 25 
26 
27 basolateral and smaller size luminal mitochondria (Figs. 2C,E), and tight junctions 
28 
29 and packed filopodia (Figs. 2C,F). Of note, dome formation was not observed in these 
30 
31 TAL cell cultures either grown on filters or on plastic plates. 
33 
34 
35 
36 Expression and processing of uromodulin in primary TAL cells 37 
38 
39 The primary TAL cultures were analyzed for the expression of functional markers, 
40 
41 using confocal microscopy (Figure 3) and immunoblotting experiments (Figure 4). A 42 
43 
44 strong  immunostaining  for  uromodulin  and  NKCC2  was  observed  in  the  TAL 
45 
46 monolayers (Fig. 3A). The staining partly overlapped, as NKCC2 is located at or in 47 
48 
vesicles close to the apical membrane, while uromodulin presented additional staining 
50 
51 in the extracellular compartment, with formation of large filaments (Figs. 3A,C). The 
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analysis confirmed that uromodulin cleavage in the primary TAL cells is similar to 
that occurring in vivo, since the vast majority of identified peptides have the same C- 
terminus (F588 residue) as urinary uromodulin [38] (Fig. 5). 
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uromodulin and NKCC2 localize to apical membrane of the TAL (Fig. 3A, lower 
1 
2 panel). The primary TAL cells also expressed a strong, apical staining for ROMK 3 
4 
5 (Fig. 3B). Distinctive uromodulin filaments were detected on the apical surface of 
6 
7 primary TAL cells obtained from wild-type kidneys, and absent in cells obtained from 8 
9 
10 uromodulin knockout kidneys (Fig. 3C). 
11 
12 Immunoblotting confirmed the expression of NKCC2 in microdissected TAL tubules 
13 
14 and  primary  TAL  cultures,  while  AQP1  and  AQP2  were  absent  (Fig.  4A).  A 
16 
17 consistent expression of NKCC2 and uromodulin was detected in primary TAL cells 
18 
19 after 4 days on low serum conditions (Fig. 4B). RT-qPCR experiments showed that 20 
21 
22 the primary TAL cultures expressed high levels of the medulla-specific NKCC2F 
23 
24 variant and lower levels of the NKCC2A variant (95 ± 26% and 5 ± 0%, respectively, 25 
26 
27 n=9), with no amplification of the cortex-specific NKCC2B variant (data not shown). 
28 
29 We next investigated whether uromodulin is appropriately sorted and secreted, as 
30 
31 occurs  in  vivo.  Apical  wash-out  experiments  showed  a  progressive  secretion  of 
33 
34 uromodulin in the apical medium, that was apparent 4-8 h after changing the medium 
35 
36 (Fig. 4C). The secretion of uromodulin from the TAL into the urine is mediated by a 37 
38 
39 conserved proteolytic cleavage in vivo [38]. Accordingly, the application of a protease 
40 
41 inhibitor cocktail (PIC) to the luminal pole of the primary TAL monolayers resulted 42 
43 
44 in a 65% reduction in the apical release of uromodulin (Fig. 4D). 
45 
46 Deglycosylation of uromodulin released in the apical medium yielded a main short 47 
48 
isoform, similar in size to the variant detected in mouse urine, and one at higher 
50 
51 molecular mass  (Figure 5).  Analysis  of  the  short  isoform by  mass  spectrometry 
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vasopressin receptor 2 (AVPR2), like in mouse kidney (Fig. 6C). Stimulation of the 
monolayers with the V2R agonist desmopressin (DDAVP) induced a dose-dependent 
increase in intracellular cAMP concentration with a maximal effect reached at ~100 
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Electrophysiological characteristics of primary TAL cells 
1 
2 Transepithelial potential (Vte) difference and electrical resistance (R) were measured 3 
4 
5 in order to seek whether the characteristic, lumen-positive voltage observed in vivo is 
6 
7 preserved in the primary TAL monolayers (Table 2). These measurements showed 8 
10 that Vte  averaged 9.4±0.8 mV (lumen-positive) and R, 73±12 ohm.cm
2  across the 
11 
12 confluent primary TAL monolayers (n=15). 
13 
14 The  transport  activity of  the  bumetanide-sensitive NKCC2  cotransporter and  the 
16 
17 recycling of K+ via ROMK are both essential for generating the lumen-positive Vte in 
18 
19 TAL  cells.  The  preservation  of  the  latter  functional  coupling  and  its  role  in 20 
21 
22 maintaining Vte  in TAL primary cells was confirmed by two different approaches 
23 
24 (Figure 6). Treatment with bumetanide (100 µM) induced a strong decrease in Vte 25 
26 
27 (from  11.5±1.4  to  2.2±0.6  mV,  control  vs.  treatment,  n=7;  p=0.01),  which  was 
28 
29 reversible  on  washout  (back  to  9.8±1.3  mV)  (Fig.  6A).  To  investigate  the  K+ 
30 
31 recycling influence and the applicability of the method to various mouse strains, we 
33 
34 generated TAL primary cultures from ROMK knockout mice [28]. The primary TAL 
35 
36 cells obtained from these mice displayed normal growth rate and morphology, but 37 
38 
39 presented a significant decrease in Vte  (9.6±0.5 vs. 2.4±0.2 mV, control vs. ROMK 
40 
41 KO, n=6; p=0.0010) (Fig. 6B). 42 
43 
44 
45 
46 Primary TAL cells respond to DDAVP, hypoxia and hypertonicity 47 
48 
We tested whether the primary TAL cells respond to stimuli influencing the activity 
50 
51 of the TAL in vivo. The primary TAL cells were shown to express the arginine 
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lipofectamin-mediated  internalization  of  an  Alexa555-conjugated  siRNA,  which 
yielded a fluorescent signal in ~50% of the cells (Fig. 7A). A similar approach was 
used to show the possibility to specifically target endogenous uromodulin with siRNA 
in primary TAL cells (Fig. 7B). 
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nM DDAVP, while a half-maximal effect (EC50) was obtained at ~5 nM DDAVP 
1 
2 (Fig. 6C). The effect of DDAVP was polarized, as shown by the difference in cAMP 3 
4 
5 concentrations obtained  after  DDAVP  applied  on  the  apical  vs.  basolateral  side 
6 
7 (7.8±2.2 vs. 119.5±21.2 pmol/mL, respectively; n=6, p<0.01) (Fig. 6D). 8 
9 
10 The effect of HIF1α and target genes such as pyruvate dehydrogenase 2 (PHD2) and 
11 
12 glucose transporter (GLUT1) was studied following a 24-h incubation of the TAL 
13 
14 cultures at low (0.2%) vs. control (21%) oxygen concentration (Fig. 6E). Compared to 
16 
17 control, the mRNA expression levels of PHD2 (1.00±0.16 vs. 5.16±0.96, respectively; 
18 
19 n=4, p=0.03) and GLUT1 (1.00±0.17 vs. 2.32±0.29, respectively; n=4, p=0.006) were 20 
21 
22 significantly  increased,  whereas  that  of  pyruvate  dehydrogenase  1  (PHD1)  was 
23 
24 unchanged (1.00±0.11 vs.  0.90±0.12; n=4).  Hypertonicity  is  known  to  stimulate 25 
26 
27 transcription activator  TonEBP  and  target  genes  such  as  heat  shock  protein  70 
28 
29 (HSP70) and aldose reductase (AR) in the TAL in vivo.  Exposure of the TAL cell 
30 
31 cultures to hypertonic medium (480 mOsm) for 6h yielded robust increase in the 
33 
34 mRNA expression levels of TonEBP (1.00±0.07 vs. 2.16±0.31; n=4, p=0.03), HSP70 
35 
36 (1.00±0.05 vs. 7.96±0.65; n=4, p=0.002) and AR (1.00±0.05 vs. 25.96±3.20; n=4, 37 
38 
39 p=0.004) (Fig. 6F).  These data demonstrate that the  primary TAL cells respond 
40 
41 appropriately to hormonal and environmental stimuli operating in the TAL in vivo. 42 
43 
44 
45 
46 Transfectability of the primary TAL cells 47 
48 
The possibility to transfect the primary TAL cells (Figure 7) was demonstrated using 
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The primary TAL cells show a high level of expression of uromodulin, that is 
processed intracellularly, sorted to the apical membrane and released in the apical 
medium, mostly through the same proteolytic cleavage occurring in vivo (Figs. 3 and 
4). To our knowledge, this is the first cellular system in which the processing of 
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DISCUSSION 
1 
2 In this report, we describe a technique that combines microdissection, enzymatic 3 
4 
5 digestion, differential sieving and culture on collagen-coated filters to obtain pure, 
6 
7 differentiated  medullary  TAL  primary  cultures  from  mice.  These  cells  (i)  are 8 
9 
10 polarized and show morphological features of the TAL; (ii) express NKCC2, ROMK 
11 
12 and uromodulin; (iii) display a lumen-positive transepithelial voltage that is sensitive 
13 
14 to bumetanide and likewise depends on ROMK activity; (iv) respond to stimuli such 
16 
17 as hypoxia, hypertonicity and vasopressin; and (v) process and secrete uromodulin 
18 
19 with typical features observed in vivo. 20 
21 
22 The technique described here yields confluent monolayers of primary TAL 
23 
24 cells approximately 12 days after seeding, with ~10 inserts per mouse kidney. The 25 
26 
27 primary  TAL  cells  show  morphological features,  including  cuboïdal  appearance, 
28 
29 height averaging 8-9  μm,  tight  junctional belts,  large  basal  and  smaller luminal 
30 
31 mitochondria, and sub-apical vesicles similar to the ultrastructural features of native 
33 
34 rodent TAL [2]. The primary TAL cells display a consistent expression of NKCC2 
35 
36 and  uromodulin, with  the  latter  identified at  the  luminal membrane and  also  as 37 
38 
39 filaments on  the apical surface of  the cells. This apical distribution of  NKCC2, 
40 
41 ROMK  and  uromodulin  in  the  TAL  cells  is  similar  to  the  in  vivo  situation. 42 
43 
44 Furthermore, the primary TAL cultures express high levels of the medulla-specific 
45 
46 NKCC2F, lower levels of NKCC2A, and no cortical NKCC2B variant, in line with 47 
48 
the micro-dissected medullary TAL segments used to generate the cultures [21]. 
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latter result confirms the functional link between the lumen-positive voltage and the 
K+  recycling through ROMK [22]. On the other hand, this experiment serves as a 
proof-of-principle  demonstration  of  the  usefulness  of  the  method  to  investigate 
transgenic mouse models relevant for TAL function. It must be noted that we could 
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uromodulin is evidenced to be similar to that observed in vivo. Uromodulin has been 
1 
2 recently pointed as a urinary biomarker relevant for renal function, chronic kidney 3 
4 
5 disease and hypertension [35]. Uromodulin is a ~105 kD glycoprotein containing 616 
6 
7 amino acids with 48 cysteine residues, three epidermal growth factor (EGF)-like 8 
9 
10 domains and a zona pellucida (ZP) domain, found in many extracellular proteins, as 
11 
12 well as  a glycosylphosphatidylinositol (GPI)-anchoring site. After trafficking and 
13 
14 maturation in TAL-lining cells, uromodulin reaches the apical plasma membrane to 
16 
17 be cleaved by unknown proteases and assembled in the urine as large polymers [43]. 
18 
19 Our studies demonstrate that the polarized secretion of uromodulin in primary TAL 20 
21 
22 cells  yields  such  filaments,  made  of  secretory  variants  exactly  similar  to  those 
23 
24 observed in mouse urine. The mTAL cellular system described here will thus be 25 
26 
27 valuable to further investigate the complex processing and function of uromodulin. 
28 
29 The  possibility  to  transfect  the  primary  TAL  cells,  as  shown  by  lipofectamin- 
30 
31 mediated internalization of siRNAs (Fig. 7), will be particularly important in that 
33 
34 context. 
35 
36 Electrophysiological  recordings  of  primary  TAL  cells  demonstrated  an 37 
38 
39 essential feature of the TAL segment, i.e. a lumen-positive Vte  that depends on the 
40 
41 activity of NKCC2 and ROMK. The Vte recorded at baseline is comparable to values 42 
43 
44 observed by microperfusion studies on isolated perfused mouse TAL tubules [12,23]. 
45 
46 Furthermore, Vte  was  reversibly abolished by  bumetanide and  also  significantly 47 
48 
attenuated in primary TAL cultures obtained from ROMK KO mice. On one hand, the 
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health and disease. 
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not observe dome formation with the primary TAL cells cultured on plastic, which 
1 
2 could  suggest  that  the  water  impermeability  of  the  TAL  is  preserved  in  this 3 
4 
5 differentiated culture system. 
6 
7 Vasopressin signaling via the V2R-cAMP pathway is a strong activator of 8 
9 
10 NKCC2 in the TAL [3,32]. We show here that V2R is expressed in the primary TAL 
11 
12 cultures and that a dose-dependent increase in cAMP follows treatment with DDAVP. 
13 
14 These results are in line with previous observations in TAL micropuncture studies and 
16 
17 microdissected TAL segments, with similar dose-dependance of cAMP generation to 
18 
19 DDAVP [5,15]. The cells lining the medullary TAL are particularly sensitive to 20 
21 
22 oxygen deprivation in view of their high metabolic activity [18]. To assess whether 
23 
24 primary TAL cells respond appropriately to hypoxic conditions, we measured the 25 
26 
27 mRNA levels of hypoxia target genes. Both the prolyl 4-hydroxylase domain protein 
28 
29 PHD2 and the glucose transporter GLUT1 were significantly increased in the primary 
30 
31 TAL cells under hypoxic conditions, contrasting with the stable expression of the 
33 
34 PHD1 isoform. These results are in line with in vivo experiments using kidneys of 
35 
36 hypoxic mice [40]. In vivo, medullary TAL cells are protected against the deleterious 37 
38 
39 effects of hypertonicity by transcription activator TonEBP and target genes HSP70 
40 
41 and AR [7,26]. We observed a similar upregulation in primary TAL cells exposed to 42 
43 
44 hypertonic treatment. 
45 
46 The availability of a differentiated TAL cellular system obtained from mouse 47 
48 
kidney opens new perspectives for the analysis of the role played by the TAL in 
48 
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Table 1. Primers used in real-time RT-PCR analyses.  
1 
2    
3 Gene product    Forward primer (5’-3’) Reverse primer (5’-3’) PCR 
4 bp 
5 
6 
Efficiency 
Arl15 TCC AGA ATG CCG TTT TGA AT CAT CCT CTG AAG AGG CAC TGT 126 1.01 ± 0.03 7 
8 Aqp1 GCT GTC ATG TAC ATC ATC GCC CAG AGG TCA TTG CGG CCA AGT GAA T 107 0.99 ± 0.02 
9 Aqp2 TCA CTG GGT CTT CTG GAT CG CGT TCC TCC CAG TCA GTG T 147 1.03 ± 0.04 
10 Avpr2 GGA AAT GGC AGT GGG GTA TT GGC ACC AGA CTG GCA TGT AT 164 0.98 ± 0.04 
11 Clcn5 TGG AGG AGC CAA TCC CTG GTG T AGA AAG CAT CGC TCA CAC TG 156 1.01 ± 0.03 
12 Glut1 TCT CTG TCG GCC TCT TTG TT GCA GAA GGG CAA CAG GAT AC 380 NT 
13 Hsp70A1 ACC ACC TAC TCG GAC AAC CA CGA AGG TCA CCT CGA TCT GT 151 1.02 ± 0.03 
14 Kcnj1 CCG TGT TCA TCA CAG CCT TCT T CCG TAA CCT ATG GTC ACT TGG G 190 1.03 ± 0.03 15 
Phd1 TTG CCT GGG TAG AAG GTC AC GCT CGA TGT TGG CTA CCA CT 306 NT 16 
17 Phd2 AGC CAT GGT TGC TTG TTA CC CTC GCT CAT CTG CAT CAA AA 299 NT 
18 Podocin GTC TAG CCC ATG TGT CCA AA CCA CTT TGA TGC CCC AAA TA 162 1.02 ± 0.03 
19 Slc12a1 A TGG GTT GTC AAC TTC TGC AA AGC AAA GAT CAA GCC TAT TGA CC 118 NT 
20 Slc12a1 B ACA GGT TTG TCC ACC TCT GC AGC AAA GAT CAA GCC TAT TGA CC 120 NT 
21 Slc12a1 F ATT GGC CTG AGC GTA GTT GT AGC AAA GAT CAA GCC TAT TGA CC 150 0.99 ± 0.04 
22 Snat3 ATT GGA GCC ATG TCC AGC TA GGC AGA ATG ATG GTG ACA GA 149 0.98 ± 0.02 23 
TonEBP GCA AGG CTA TGC AAG TGG AG GTC CTC AGG TGG TGG TGA G 152 0.97 ± 0.04 24 
25 Umod TTG CGA AGA ATG CAG GGT AG TGG CAC TTT CTG AGG GAC AT 156 1.01 ± 0.02 
26 Actb TGC CCA TCT ATG AGG GCT AC CCC GTT CAG TCA GGA TCT TC 102 1.02 ± 0,02 27 
Cyclophilin CGT CTC CTT CGA GCT GTT TG CCA CCC TGG CAC ATG AAT C 139 1.02 ± 0.02 28 Gapdh TGC ACC ACC AAC TGC TTA GC GGA TGC AGG GAT GGG GGA GA 176 1.04 ± 0.03 29 
30 Hprt1 ACA TTG TGG CCC TCT GTG TG TTA TGT CCC CCG TTG ACT GA 162 0.99 ± 0.01 
31 36B4 CTT CAT TGT GGG AGC AGA CA TTC TCC AGA GCT GGG TTG TT 150 0.99 ± 0.01 
32 
33 
34 
35 The primers were designed using Beacon Design 2.0 (Premier Biosoft International, 
36 Palo Alto, CA). NT, not tested. 
37 
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Segment V (mV) R (Ohm.cm2) Ref. 
Mouse PTC -0.8 ± 0.1 54 ± 1 Terryn et al. 2009 
Rabbit mTAL + 6-8 212 Jans et al. 2000 
Mouse mTAL - 75-258 Wu et al. 1991 
Mouse mTAL + 9.4 ± 0.8 73 ± 12 This study 
 
Table 2. Electrophysiological characteristics of primary TAL cells from mouse 
1 kidney. 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 PTC, proximal tubule cells (grey box); mTAL, medullary thick ascending limb (open boxes) 
19 
20 
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41 
42 
43 
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complete and two flanking TAL cells positioned on the filter (C; scale bar, 2 μm). 
Magnified panels illustrate the microvilli and endoplasmic reticulum (D), 
mitochondria (E) and apical tight junctions and filopodia (F). Scale bar, 1 μm. 
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32 
LEGENDS TO FIGURE 
1 
2 
3 
4 
5 Figure 1. Morphological selection of tubule segments. 
6 
7 A.  Representative phase  contrast  images  of  segments  obtained  after  collagenase 8 
9 
10 treatment of mouse kidneys: proximal convoluted tubules (PCT); proximal straight 
11 
12 tubules (PST); thick ascending limbs (TAL); and collecting ducts (CD). Scale bar, 
13 
14 100 μm. B-C. Segment-specific marker genes (glomerulus: podocin; PT: AQP1 and 
16 
17 SNAT3; TAL: NKCC2 and UMOD; CD: AQP2) were used to demonstrate the purity 
18 
19 for each fraction of collected tubule segments using reverse transcriptase PCR (B) and 20 
21 
22 SYBR green quantitative PCR (n=6) (C). 
23 
24 
25 
26 
27 Figure 2. Morphological characterizations of primary TAL cells. 
28 
29 A. Phase contrast light microscopy demonstrating the development of TAL primary 
30 
31 cultures.  At  day  0,  approximately 50  TAL  tubules  were  placed  on  a  0.33  cm2 
33 
34 permeable filter support. Formation of small islands of cells was identified after 5 
35 
36 days. The islands expanded and joined around day 10. The filters were confluent after 37 
38 
39 approximately 12 days. Scale bar, 200 μm. 
40 
41 B. Toluidine blue-stained semi-thin section of confluent primary TAL cells on a 42 
43 
44 permeable filter support (Bl, basolateral side; scale bar, 2 µm). 
45 
46 C-F.  Representative  images  obtained  by  transmission  electron  microscopy.  A 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
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lysates of primary TAL cells (1 filter per lane, 4 days low serum conditions). 
C. Uromodulin detection in the apical medium of TAL monolayers grown on filters. 
Secreted uromodulin appears between 4-8h after the wash-out of apical medium (20 
μl are loaded in each lane, with baseline (BL) level corresponding to the last 48h of 
30 
 
15 
Figure 3. Immunolocalization of NKCC2, ROMK and uromodulin in mouse 
1 
2 primary TAL cultures. 3 
4 
5 A. Immunofluorescence staining for NKCC2 and uromodulin (UMOD) in primary 
6 
7 TAL cells and native mouse kidney sections. NKCC2 is located within the apical 8 
9 
10 membrane, whereas uromodulin shows both apical and additional staining at the 
11 
12 extracellular compartment, where it forms filaments (z-scan). A similar pattern is 
13 
14 observed in the TAL monolayers and mouse kidney. Scale bar, 10 μm. 
16 
17 B. Immunofluorescent staining for ROMK in primary TAL cells. ROMK staining is 
18 
19 concentrated at the apical membrane of the cells (confocal z-scan). Scale bar, 100 μm. 20 
21 
22 C. Uromodulin filaments present at the apical membrane of fully differentiated (4 
23 
24 days low serum conditions) primary TAL cells (wild-type kidneys) are evidenced by 25 
26 
27 immunofluorescence microscopy. These filaments are absent in primary TAL cells 
28 
29 obtained from uromodulin knockout kidneys (inset). Scale bar, 100 μm. 
30 
31 
32 
33 
34 Figure 4. Uromodulin processing in mouse primary TAL cells. 
35 
36 A. Western blot analysis shows NKCC2 expression in primary TAL cells (prTAL, 1 37 
38 
39 confluent filter after 4 days in low serum conditions), as compared with a pool of 30 
40 
41 micro-dissected TAL, PT and CD segments and total mouse kidney (15 µg total 42 
43 
44 protein). The PT (AQP1) and CD (AQP2) markers are absent in the TAL cells. 
45 
46 B. Western blot demonstrates consistent NKCC2 and uromodulin expression in three 
59 
60 
61 
62 
63 
64 
65 
31 
 
20 
37 
culture). Upon longer exposure of the film to the blotting membrane, uromodulin 
1 
2 secretion appears already 2 h after washing. 3 
4 
5 D. Treatment of confluent TAL monolayers with protease inhibitor cocktail (PIC) for 
6 
7 16h (apical side) significantly reduced the cleavage of uromodulin and its release into 8 
9 
10 the apical medium. Representative immunoblots, with 20 µl of apical medium loaded 
11 
12 in each lane. Quantification by densitometry reveals that the level of uromodulin 13 
14 
15 secreted is reduced after PIC treatment (35.3 ± 13 % of control value; n=4; p=0.01). 
16 
17 
18 
19 Figure 5. NanoLC–ESI-MS/MS analysis of uromodulin expressed by primary 
21 
22 TAL cells. 
23 
24 A.  Western blot analysis (anti-uromodulin) of deglycosylated (PNGaseF) purified 25 
26 
27 proteins  from  primary  TAL  cell  apical  medium  (prTAL)  or  urine.  The  short 
28 
29 uromodulin isoform released by primary TAL cells has similar molecular weight as 30 
31 
32 the urinary protein (red arrows). B. Coomassie-stained gel showing deglycosylated 
33 
34 proteins purified from apical primary TAL cell medium (prTAL) or urine-purified 35 
36 uromodulin. The red arrows indicate the band that was analyzed by MS. C. Mouse 
38 
39 uromodulin protein sequence (Uniprot accession Q91X17). MS sequence coverage of 
40 
41 uromodulin from primary TAL apical medium is shown (62% over the entire protein). 42 
43 
44 The C-terminal most abundant peptide identified by MS analysis is shown in bold 
45 
46 underlined. This peptide ends  at F588,  the same C-terminal residue reported for 47 
48 
49 murine urinary uromodulin [38]. D. MS profile of differently charged (z2+, z3+ or 
50 
51 z4+)  C-terminal  peptides  from  uromodulin released  in  primary  TAL  cell  apical 52 
53 
54 medium. The large majority of peptides ends at residue F588. E.  Representative 
55 
56 MS/MS spectra confirming the identity of C-terminal peptides 
57 
58 573DSTSEQCKPTCSGTRF588 and 573DSTSEQCKPTCSGTRFR589. 
59 
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49 
Figure 6. Functional characterization of primary TAL cells. 
1 
2 A. A lumen-positive transepithelial voltage (Vte) averaging 11.5±1.4 mV is observed 3 
4 
5 at baseline (Bl) across primary TAL monolayers. Vte is reduced to 2.2±0.6 mV upon 
6 
7 treatment with 100 μM bumetanide (Bum; n=7; p=0.001), with recovery 20 min after 8 
9 
10 wash-out. 
11 
12 B. Vte  is significantly reduced in TAL monolayers obtained from ROMK knockout 13 
14 (ko)  vs.  wild-type  (ctrl)  mice  (n=6;  p<0.001).  Inset:  reverse  transcriptase-PCR 
16 
17 analysis showing  lack  of  ROMK  mRNA  expression in  TAL  cells  from  ROMK 
18 
19 knockout mice. 20 
21 
22 C. The vasopressin type-2 receptor (AVPR2) is expressed in primary TAL cells 
23 
24 (inset). Treatment of TAL monolayers with DDAVP (5min) yields a dose-dependent 25 
26 
27 increase in intracellular cAMP concentration (n=4 for each concentration). 
28 
29 D. The effect of DDAVP is markedly larger when applied on the basolateral side of 
30 
31 the  primary  TAL  monolayers  (cAMP  levels  after  5  min  apical  vs.  basolateral 
33 
34 exposure to 10 nM DDAVP; n=6; p<0.01). 
35 
36 E. Quantitative PCR analyses show a typical response to hypoxia, with increased 37 
38 
39 pyruvate  dehydrogenase  2  (PHD2;  5.16±0.96  vs.  1.00±0.16;  n=4;  p=0.03)  and 
40 
41 glucose  transporter  (GLUT1;  2.32±0.29  vs.   1.00±0.17;  n=4;  p<0.01)  mRNA 42 
43 
44 expression levels) contrasting with stable PHD1 in primary TAL cells exposed for 24 
45 
46 h to 0.2% vs. 21% oxygen (control). 47 
48 
F. Quantitative PCR analyses demonstrate increased tonicity-responsive enhancer- 
50 
51 binding protein (TonEBP; 2.16±0.31 vs. 1.00±0.07; n=4; p=0.03), heat shock protein 
52 
53 70 (HSP70; 7.96±0.65 vs. 1.00±0.05 ; n=4; p=0.002) and aldose reductase (AR; 54 
55 
56 25.96±3.20  vs.  1.00±0.05;  n=4;  p=0.004)  upon  exposure  of  the  primary  TAL 
57 
58 monolayers for 6 h to hypertonic (480 mOsm) vs. control (320 mOsm) medium. 
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Figure 7. Transfectability of primary TAL cells. 
1 
2 A.  Lipofectamin-mediated transfection of  BLOCK-iTTM  Alexa555 Red siRNA  in 3 
4 
5 primary TAL cells, showing fluorescent staining (i.e. internalization of the Alexa555 
6 
7 siRNA) in a large proportion of cells. Control primary TAL cells were transfected 8 
9 
with a non-fluorescent SilencerRNegative control siRNA. Scale bar, 50 μm. 
11 
12 B. Specific siRNA targeting of endogenous uromodulin (UMOD) mRNA expression 
13 
14 in primary TAL cells. Primary TAL cells transfected with UMOD targeting siRNAs 
16 
17 show a significant reduction in Umod (100 ± 2% vs. 49 ± 7%, respectively; p<0.001; 
18 
19 n=6), whereas the expression of the non-specific target Clcn5 is not affected (100 ± 20 
21 
22 8%  vs.  91  ±  8%,  respectively; n=6). Control primary TAL  cells  were  similarly 
23 
24 transfected with a SilencerRNegative control siRNA. 25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
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41 
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43 
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MOUSE UROMODULIN 
 
MGIPLTWMLL VMMVTSWFTL AEASNSTEAR RCSECHNNAT CTVDGVVTTC 50 
SCQTGFTGDG LVCEDMDECA TPWTHNCSNS SCVNTPGSFK CSCQDGFRLT 100 
PELSCTDVDE CSEQGLSNCH ALATCVNTEG DYLCVCPEGF TGDGWYCECS 150 
PGSCEPGLDC LPQGPDGKLV CQDPCNTYET LTEYWRSTEY GVGYSCDAGL 200 
HGWYRFTGQG GVRMAETCVP VLRCNTAAPM WLNGSHPSSS EGIVSRTACA 250 
HWSDQCCRWS TEIQVKACPG GFYIYNLTAP PECNLAYCTD PSSVEGTCEE 300 
CRVDEDCISD NGRWRCQCKQ DSNITDVSQL EYRLECGAND IKMSLRKCQL 350 
QSLGFMNVFM YLNDRQCSGF SESDERDWMS IVTPARNGPC GTVLRRNETH 400 
ATYSNTLYLA NAIIIRDIII RMNFECSYPL DMKVSLKTSL QPMVSALNIS 450 
LGGTGKFTVR MALFQSPTYT QPHQGPSVML STEAFLYVGT MLDGGDLSRF 500 
VLLMTNCYAT PSSNSTDPVK YFIIQDSCPR TEDTTIQVTE NGESSQARFS 550 
VQMFRFAGNY DLVYLHCEVY LCDSTSEQCK PTCSGTRFRS GNFIDQTRVL 600 
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